Why 23andMe Stock Has Jumped 16% So Far This Week

What happened
Shares of the genetic-testing company 23andMe(NASDAQ:ME) gained another 16% through Thursday’s close this week, according to data from S&P Global Market Intelligence. The biotech’s stock is now up by more than 34% over the past two weeks.

Click here to view the original article.